Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia
CRENESSITY, the first new treatment available in 70 years to the classic congenital adrenal hyperplasia (CAH) community, offers a paradigm-shifting treatment approach FDA approval supported by data from the largest-ever clinical trial program in pediatric and adult patients with classic CAH CRENESSI
BIOVAXYS ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT AND ANNOUNCES DEBT SETTLEMENT AGREEMENT
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Dec. 13, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company“) is pleased to announce that it has closed t
TEAMSTERS DEMAND REGULATORY AGENCIES HOLD AUTONOMOUS VEHICLE COMPANIES TO ACCOUNT AS GM HALTS FUNDING FOR CRUISE
Teamsters Push for Good Jobs, Safe Streets While AVs Continue to Wreak Havoc on Public Roads SAN FRANCISCO, Dec. 13, 2024 /PRNewswire/ — In response to news that General Motors (GM) will halt funding for its Autonomous Vehicle (AV) subsidiary Cruise, Peter Finn, Teamsters Western Region Int
FDA Approves New Treatment for Congenital Adrenal Hyperplasia
SILVER SPRING, Md., Dec. 13, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Crenessity (crinecerfont) to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like hormone) levels in adults and pediatric patients 4 years of age and old
Media Advisory – Prime Minister’s itinerary for Saturday, December 14, 2024
OTTAWA, ON, Dec. 13, 2024 /CNW/ – Greater Vancouver Area, British Columbia No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
S&P Dow Jones Indices Announces Dow Jones Sustainability Indices 2024 Review Results
NEW YORK and AMSTERDAM, Dec. 13, 2024 /PRNewswire/ — S&P Dow Jones Indices (“S&P DJI”), the world’s leading index provider, today announced the results of the annual Dow Jones Sustainability Indices (DJSI) rebalancing and reconstitution. The DJSI are float-adjusted
Agriculture & Natural Solutions Acquisition Corporation Receives FIRB Approval In Connection with Previously Announced Business Combination
NEW YORK, Dec. 13, 2024 /PRNewswire/ — Agriculture & Natural Solutions Acquisition Corporation, a special purpose acquisition company (“ANSC”), announced today that the Treasurer of Australia (the “Treasurer”) on December 12, 2024 (Australian Eastern Daylight Time)
SHOBHA OFFERING MAJOR SALE AND EXCITING NEW MEMBERSHIPS
NEW YORK, Dec. 13, 2024 /PRNewswire/ — Premier NYC hair removal salon Shobha is offering some of their lowest prices ever through holiday discounts and exciting new memberships. Shobha’s already-reduced 3- and 6-packs are being discounted an additional 15% through 12/31/24, and are ava
CenterPoint Energy Declares Regular Common Stock Dividend of $0.2200
HOUSTON, Dec. 13, 2024 /PRNewswire/ — CenterPoint Energy, Inc.’s (NYSE: CNP) Board of Directors today declared a regular quarterly cash dividend of $0.2200 per share on the issued and outstanding shares of Common Stock payable on March 13, 2025 to shareholders of record at the close o
Blood Market to Grow by USD 2.6 Billion (2024-2028), Report on AI-Driven Market Transformation and Growth in Hospitals and Blood Banks – Technavio
NEW YORK, Dec. 13, 2024 /PRNewswire/ — Report with the AI impact on market trends – The global blood market size is estimated to grow by USD 2.60 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.94% during the forecast period. Rising n
